Expression of nerve growth factor receptor mRNA during early development of the chicken embryo: emphasis on cranial ganglia

Development ◽  
1990 ◽  
Vol 108 (4) ◽  
pp. 693-704 ◽  
Author(s):  
F. Hallbook ◽  
C. Ayer-Lelievre ◽  
T. Ebendal ◽  
H. Persson

In situ hybridization with beta-nerve growth factor receptor (NGF-R) oligonucleotide probes was used to study NGF-R mRNA expression in early chicken embryos. Sections through the region of the visceral arches showed high levels of NGF-R mRNA in mesenchyme of the visceral arches, neural tube and myotomes. Labelling was also seen over E3 primordium of the trigeminal ganglion (V) and in the placodal thickening of the petrosal (IX) and nodose (X) ganglionic primordia. In the E5 embryo, all cranial sensory ganglia (V, VII, VIII, IX, X) expressed NGF-R mRNA although at varying levels with higher levels in the ganglia of the Vth, IXth and Xth cranial nerves than in ganglia of the VIIth and the VIIIth nerves. Within ganglia of the Vth, IXth and Xth cranial nerves, levels of NGF-R mRNA were higher in regions containing placode-derived neurons, than in regions with neural-crest-derived neurons. The placode-derived nodose ganglion (X) expressed NGF-R mRNA at all stages of development. In the E15 embryo and later in development, two thirds of the large neuron-like cells expressed high levels of NGF-R mRNA. Our results show that expression of NGF-R mRNA, in peripheral neurons, is not restricted to cells of neural crest origin. We also show a transient expression of NGF-R mRNA early in development in a wide range of non-neuronal differentiating cells. The high level of NGF-R mRNA in early differentiating tissues suggest that the NGF-R plays a wider role during development than previously anticipated.

Nature ◽  
2011 ◽  
Vol 470 (7334) ◽  
pp. 424-424 ◽  
Author(s):  
Alexander D. Boiko ◽  
Olga V. Razorenova ◽  
Matt van de Rijn ◽  
Susan M. Swetter ◽  
Denise L. Johnson ◽  
...  

Nature ◽  
2010 ◽  
Vol 466 (7302) ◽  
pp. 133-137 ◽  
Author(s):  
Alexander D. Boiko ◽  
Olga V. Razorenova ◽  
Matt van de Rijn ◽  
Susan M. Swetter ◽  
Denise L. Johnson ◽  
...  

1986 ◽  
Vol 486 (1 Neurofibromat) ◽  
pp. 115-123 ◽  
Author(s):  
ALONZO H. ROSS ◽  
MEENHARD HERLYN ◽  
GERD G. MAUL ◽  
HILARY KOPROWSKI ◽  
MARK BOTHWELL ◽  
...  

2021 ◽  
Vol 11 (1) ◽  
pp. 204589402199052
Author(s):  
Chiaki Goten ◽  
Soichiro Usui ◽  
Shin-ichiro Takashima ◽  
Oto Inoue ◽  
Hirofumi Okada ◽  
...  

Pulmonary arterial hypertension (PAH) remains a disease with a poor prognosis, so early detection and treatment are very important. Sensitive and non-invasive markers for PAH are urgently required. This study was performed to identify sensitive markers of the clinical severity and prognosis of PAH. Patients diagnosed with PAH (n = 30) and control participants (n = 15) were enrolled in this observational study. Major EPC and MSC markers (including CD34, CD133, VEGFR2, CD90, PDGFRα, and NGFR) in peripheral blood mononuclear cells (PBMNCs) were assessed by flow cytometry. Associations of these markers with hemodynamic parameters (e.g. mean pulmonary arterial pressure, pulmonary vascular resistance, and cardiac index) were assessed. Patients with PAH were followed up for 12 months to assess the incidence of major adverse events, defined as death or lung transplantation. Levels of circulating EPC and MSC markers in PBMNCs were higher in patients with PAH than in control participants. Among the studied markers, nerve growth factor receptor (NGFR) was significantly positively correlated with hemodynamic parameters. During the 12-month follow-up period, major-event-free survival was significantly higher in patients with PAH who had relatively low frequencies of NGFR positive cells than patients who had higher frequencies. These results suggested that the presence of circulating NGFR positive cells among PBMNCs may be a novel biomarker for the severity and prognosis of PAH.


Sign in / Sign up

Export Citation Format

Share Document